TREM-1 promotes survival during septic shock in mice

European Journal of Immunology

Volumn 37, Issue 2, 2007, Pages 456-466

  Gibot, Sébastien ^a,b,c   Massin, Frederic ^d   Marcou, Markella ^e   Taylor, Valerie ^c   Stidwill, Ray ^c   Wilson, Peter ^e   Singer, Mervyn ^c   Bellingan, Geoff ^c  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITÉ DE LORRAINE   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Innate immunity; Rodent; siRNA

Indexed keywords

CELL PROTEIN; ENDOTOXIN; SMALL INTERFERING RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL 1; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; CYTOTOXICITY; IN VIVO STUDY; INFECTION RISK; INFLAMMATION; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY BURST; SEPTIC SHOCK; SURVIVAL; ANIMAL; C57BL MOUSE; ENDOTOXEMIA; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PERITONITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ENDOTOXEMIA; FLOW CYTOMETRY; INFLAMMATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PERITONITIS; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SHOCK, SEPTIC;

EID: 33947716084     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636387     Document Type: Article

References (40)

1. Diefenbach, A. and Raulet, D. H., Innate immune recognition by stimulatory immunoreceptors. Curr. Opin. Immunol. 2003. 15: 37-44.
2. Kubagawa, H., Burrows, P. D. and Cooper, M. D., A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 1997 94: 5261-5266.
3. Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S. et al., NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 1999. 189: 787-796.
4. Dietrich, J., Cella, M., Seiffert, M., Buhring, H. J. and Colonna, M., Cutting edge: Signal-regulatory protein β1 is a DAP12-associated activating receptor expressed on myeloid cells. J. Immunol. 2000. 164: 9-12.
5. Bouchon, A., Dietrich, J. and Colonna, M., Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 2000. 164: 4991-4995.
6. Daws, M. R., Lanier, L. L., Seaman, W. E. and Ryan, J. C., Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur. J. Immunol. 2001. 31: 743-791.
7. Chung, D. H., Seaman, W. E. and Daws, M. R., Characterization of TREM-3, an activating receptor on mouse macrophages: Definition of a family of single Ig domain receptors on mouse chromosome 17. Eur. J. Immunol. 2002. 32: 59-66.
8. Bouchon, A., Hernandez-Munain, C., Cella, M. and Colonna, M., A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 2001. 194: 1111-1122.
9. Colonna, M., TREMs in the immune system and beyond. Nat. Rev. Immunol. 2003. 3: 1-9.
10. McVicar, D. W., Taylor, L. S., Gosselin, P., Willette-Brown, J., Mikhael, A. I., Geahlen, R. L., Nakamura, M. C. et al., DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J. Biol. Chem. 1998. 273: 32934-32942.
11. Colonna, M. and Fachetti, F., TREM-1: A new player in acute inflammatory responses. J. Infect. Dis. 2003. 187 suppl 2: S397-S401.
12. Bouchon, A., Fachetti, F., Weigand, M. A. and Colonna, M., TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001. 410: 1103-1107.
13. Bleharski, J. R., Kiessler, V., Buonsanti, C., Sieling, P. A., Stenger, S., Colonna, M. and Modlin, R. L., A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J. Immunol. 2003. 170: 3812-3818.
14. Radsak, M. P., Salih, H. R., Rammensee, H. G. and Schild, H., Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: Differential regulation of activation and survival. J. Immunol. 2004. 172; 4956-4963.
15. Gibot, S., Kolopp-Sarda, M. N., Bene, M. C., Bollaert, P. E., Lozniewski, A., Mory F., Levy, B. and Faure, G. C., A soluble form of the triggering receptor expressed on mycloid cells-1 modulates the inflammatory response in murine sepsis. J. Exp. Med. 2004. 200: 1419-1426.
16. Hamerman, J. A., Tchao, N. K., Lowell, C. A. and Lanier, L. L., Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 2005. 6: 579-586.
17. Lucas, M., Daniel, L., Tomasello, E., Guia, S., Horschowski, N., Aoki, N., Figarella-Branger, D. et al., Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice. Eur. J. Immunol. 2002. 32: 2653-2663.
18. Bakker, A. B., Hoek, R. M., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R. et al., DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 2000. 13: 345-353.
19. Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A. et al., Sequence-specific potent induction of interferon-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 2005. 11: 263-270.
20. Knapp, S., Gibot, S., de Vos, A., Versteeg, H. H., Colorma, M. and van der Poll, T., Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human enclotoxemia. J. Immunol. 2004. 173: 7131-7134.
21. Gibot, S., Massin, F., Le Renard, P., Bene, M. C., Faure, G. C., Bollaert, P. E. and Levy, B., Surface and soluble triggering receptor expressed on myeloid cells-1: Expression patterns in murine sepsis. Crit. Care Med. 2005. 33: 1787-1793.
22. Cohen, J., The immunopathogenesis of sepsis. Nature 2002. 420: 885-891.
23. Gibot, S., Cravoisy, A., Levy, B., Bene, M. C., Faure, G. C. and Bollaert, P. E., Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N. Engl. J. Med. 2004. 350: 451-458.
24. Nochi, H., Aoki, N., Oikawa, K., Yanai, M., Takiyama, Y., Atsuta, Y., Kobayashi, H. et al., Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. Am. J. Pathol. 2003. 162: 1191-1201.
25. Gibot, S., Buonsanti, C., Massin, F., Romano, M., Kolopp-Sarda, M. N., Benigni, F., Faure, G.C. et al., Modulation of the triggering receptor expressed on the myeloid cells type 1 pathway in murine septic shock. Infect. Immun. 2006. 74: 2823-2830.
26. Turnbull, I. R., McDunn, J. E., Takai, T., Townsend, R. R., Cobb, J. P. and Colonna, M., DAP12 (KABAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J. Exp. Med. 2005. 202: 363-269.
27. Hannon, G. J. and Rossi, J. J., Unlocking the potential of the human genome with RNA interference. Nature 2004. 431: 371-378.
28. Song, E., Lee, S. K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J. et al., RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 2003. 9: 347-351.
29. Wesche-Soldato, D. E., Chung, C. S., Lomas-Neira, J., Doughty, L. A., Gregory, S. H. Ayala, A., In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 2005. 106: 2295-2301.
30. Matsuyama, W., Watanabe, M., Shirahama, Y., Hirano, R., Matsuyama, H., Higashimoto, H., Osame, M. and Arimura, K., Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation. J. Immunol. 2006. 176: 1928-1936.
31. Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K. and Kitani, A., IL-13 signalling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 2006. 12: 99-106.
32. Echtenacher, B., Weigl, K., Lehn, N. and Mannel, D. N., Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect. Immun. 2001. 69: 3550-3555.
33. Fisher, C. J. Jr, Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E. et al., Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The soluble TNF receptor sepsis study group. N. Engl. J. Med. 1996. 334: 1697-1702.
34. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N. and Braun, M. M., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 2001. 345: 1098-1104.
35. Carpenter, K. J., Buckland, K. F., Xing, Z. and Hogaboam, C. M., Intrapulmonary, adenovirus-mediated overexpression of KARAP/DAP12 enhances fungal clearance during invasive aspergillosis. Infect. Immun. 2005. 73: 8402-8406.
36. Greenberg, S. and Grinstein, S., Phagocytosis and innate immunity. Curr. Opin. Immunol. 2002. 14: 136-145.
37. Vignais, P. V., The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell. Mol. Life Sci. 2002. 59: 1428-1459.
38. Condliffe, A. M., Davidson, K., Anderson, K. E., Ellson, C. D., Crabbe, T., Okkenhaug, K., Vanhaesebroeck, B. et al., Sequential activation of class IB and class IA P13 K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005. 106: 432-440.
39. Helming, L., Bose, J., Ehrchen, J., Schiebe, S., Frahm, T., Geffers, R., Probst-Kepper, M. et al., 1alpha, 25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 2005. 106: 4351-4358.
40. Brealey, D., Karyampudi, S., Jacques, T. S., Novelli, M., Stidwill, R., Taylor, V, Smolenski, R. T. and Singer, M., Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004. 286: R491-497.